Moreover, results of clinical observation indicated that the rs6478974 TT genotype could inhibit the susceptibility to epilepsy by reducing the levels of transforming growth factor beta receptor 1 (TGFBR1) mRNA, which is a target of let-7b (Zheng et al., 2021). The gene discussed is TGFBR1; the disease is epilepsy.